APA (7th ed.) Citation

TM, N., TS, T., & GH, N. (2025). Alopecia Associated With the Use of Immune Checkpoint Inhibitors: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System. International journal of dermatology, 64(8), 1512. https://doi.org/10.1111/ijd.17696

Chicago Style (17th ed.) Citation

TM, Nguyen, Tran TS, and Nguyen GH. "Alopecia Associated With the Use of Immune Checkpoint Inhibitors: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System." International Journal of Dermatology 64, no. 8 (2025): 1512. https://doi.org/10.1111/ijd.17696.

MLA (9th ed.) Citation

TM, Nguyen, et al. "Alopecia Associated With the Use of Immune Checkpoint Inhibitors: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System." International Journal of Dermatology, vol. 64, no. 8, 2025, p. 1512, https://doi.org/10.1111/ijd.17696.